| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491001A1 Novel use of lipopeptide preparations |
| 01/08/2004 | CA2490765A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | CA2490282A1 Use of casein peptides for treating hypertension |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378520A1 Cyclic single strand trispecific antibody |
| 01/07/2004 | EP1378515A1 Peptides for inducing apoptosis in tumor cells |
| 01/07/2004 | EP1377830A2 Arrays for determining binding of biomolecules |
| 01/07/2004 | EP1377308A1 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 01/07/2004 | EP1377306A1 Serum albumin binding moieties |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1465586A Cyclic Wushengtai and preparation process thereof |
| 01/07/2004 | CN1133649C Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 01/06/2004 | US6673769 Hybrid polypeptide |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375513A1 Immunopotentiators |
| 01/02/2004 | EP1375511A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 01/02/2004 | EP1374885A1 Use of at least one peptide of alpha-s2 casein with inhibiting activity of ACE for the preparation of medicaments and foodstuffs |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373305A1 Process for producing trunkamide a compounds |
| 01/02/2004 | EP1373304A1 INTEGRIN ALPHA IIbBETA 3 ACTIVIVING PEPTIDES AND THEIR USE |
| 01/02/2004 | EP1373303A1 Novel peptide ligands of leukocyte integrins |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372688A2 Somatostatin antagonists |
| 01/02/2004 | EP1372686A4 Methods and compositions for peptide synthesis |
| 01/02/2004 | EP1372686A2 Methods and compositions for peptide synthesis |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1015495B1 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002582 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/01/2004 | US20040002469 Administering genetic engineered polynucleotide which codes heat shock protein; induce immunology response |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002441 Antitumor agents; anticancer agents; bactericides; polymerase chain reactions |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2003087137A3 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 12/31/2003 | WO2003072059A3 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| 12/31/2003 | WO2003072039A3 Cosmetic formulations containing l-arginine oligomers |
| 12/31/2003 | WO2003066814A3 Peptide-dependent upregulation of telomerase expression |
| 12/31/2003 | WO2003059937A3 Synthetic ion channels |
| 12/31/2003 | WO2003051909A3 Process for the manufacture of pharmaceutically acceptable salts of a compound |
| 12/31/2003 | WO2003027122A3 Lanthanide binding tags |
| 12/31/2003 | WO2003006492A3 Biologically active peptides |
| 12/31/2003 | WO2002066984A3 Arrays for determining binding of biomolecules |
| 12/31/2003 | WO2000043409A3 Alpha-conotoxin peptides |
| 12/31/2003 | CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 12/31/2003 | CN1132624C Compsns. comprising antifungal agent and acetate buffer |
| 12/31/2003 | CA2491196A1 Materials and methods for inductions of immune tolerance |
| 12/30/2003 | US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 12/30/2003 | US6670446 N1 modified glycopeptides |
| 12/30/2003 | US6670324 Cyclic peptide antifungal agents |
| 12/30/2003 | US6670157 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use |
| 12/30/2003 | US6670142 Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/30/2003 | US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes |
| 12/30/2003 | US6669945 Universal T-cell epitopes for anti-malarial vaccines |
| 12/30/2003 | CA2256620C A process for preparing certain aza cyclohexapeptides |
| 12/25/2003 | WO2003106682A1 Hla-a24-restricted cancer antigen peptide |
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236242 Viricides |
| 12/25/2003 | US20030236197 Modulators of beta-amyloid peptide aggregation |
| 12/25/2003 | US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 12/25/2003 | US20030236185 Novel two Gonadotropin releasing hormones and a method to isolate the same |
| 12/25/2003 | US20030236184 Novel polynucleotides encoding lamprey GnRH-III |
| 12/25/2003 | US20030235853 Solid phase synthesis; for drug screening |
| 12/25/2003 | US20030235835 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
| 12/25/2003 | US20030235815 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
| 12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | WO2003106643A2 Novel polynucleotides encoding lamprey gnrh-iii |
| 12/24/2003 | WO2003106615A2 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 12/24/2003 | WO2003106491A2 Cell penetrating peptides |
| 12/24/2003 | WO2003105907A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | WO2003105880A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/24/2003 | WO2003078451A3 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 12/24/2003 | WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | WO2003032900A3 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1131712C Colostrinin and use thereof |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489224A1 Novel polynucleotides encoding lamprey gnrh-iii |
| 12/24/2003 | CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | CA2487342A1 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 12/24/2003 | CA2477878A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/23/2003 | US6667389 Technetium-99m labeled peptides for imaging |
| 12/23/2003 | CA2149207C Compounds that inhibit t cell proliferation and methods using the same |
| 12/18/2003 | WO2003104269A1 Synthesis of the peptide cgggqrlgdqwavghlmnh2, labelling method |
| 12/18/2003 | WO2003104268A1 Par-2-activating peptide derivative and pharmaceutical composition using the same |